Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physical attenuation of X-rays by iodine atoms refers to the process by which iodine, due to its high atomic number (Z = 53), absorbs and scatters X-ray photons more effectively than most biological tissues. This property is exploited in medical imaging, particularly in computed tomography (CT) and other X-ray-based modalities, where iodinated contrast agents are used to enhance image contrast between different tissues or vascular structures. The attenuation of X-rays occurs primarily through Compton scattering and photoelectric absorption. Photoelectric absorption is highly dependent on the atomic number (Z) of the material; higher Z materials like iodine have much greater photoelectric absorption compared to soft tissue elements. Iodine’s K-shell binding energy (K-edge) is 33.2 keV, making it especially effective at absorbing X-rays at these energies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical attenuation of X-rays by iodine atoms.